Drugs / AVR118
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00765466 | Oct 2007 → May 2010 | cancer | McGill University | Terminated | No outcome recorded |
| Phase 2 | NCT00127517 | Mar 2005 → Aug 2006 | cancer | Advanced Viral Research Corp | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVR118 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00127517 ↗ |
| Modality | Oligonucleotide (other) | “peptide-nucleic acid solution AVR118” NCT00127517 ↗ |
| Route | Subcutaneous | “AVR118 subcutaneously” NCT00765466 ↗ |